Clinical Trial Update: Anti-malaria MAb in Malian Children [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of an anti-malaria monoclonal antibody in Malian children has completed, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Anti-malaria monoclonal antibody

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Plasmodium Falciparum Infection, Malaria | Phase 2 | Status: COMPLETED | Results posted: 2024-07-10